A carregar...
Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
The advancement of cancer immunotherapy faces barriers which limit its efficacy. These include weak immunogenicity of the tumor, as well as immunosuppressive mechanisms which prevent effective antitumor immune responses. Recent studies suggest that aberrant expression of cancer testis antigens (CTAs...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3477552/ https://ncbi.nlm.nih.gov/pubmed/23097673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/760965 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|